Renal damage is one of the
most frequent and serious manifestations of systemic lupus erythematosus (SLE).
Even if this disease is the prerogative of female adults, it can affect
children especially during the peri-pubertal period. The aim of this work is to
highlight the clinical-biological and progressive characteristics of lupus
nephropathy in children.
References
[1]
Klippel, J.H. (1997) Systemic Lupus Erythematosus: Demographics, Prognosis, and Outcome. The Journal of Rheumatology, 48, 67-71.
[2]
Cameron, J.S. (1993) What Is the Role of Long-Term Cytotoxic Agents in the Treatment of Lupus Nephritis. Journal of Nephrology, 6, 172-176.
[3]
Frampton, G., Hicks, J. and Cameron, J.S. (1991) Significance of Anti-Phospholipid Antibodies in Patients with Lupus Nephritis. Kidney International, 39, 1225-1231.
https://doi.org/10.1038/ki.1991.155
[4]
Austin, H.A., Boumpas, D.T., Vaughan, E.M. and Balow, J.E. (1994) Predicting Renal Outcomes in Severe Lupus Nephritis: Contributions of Clinical and Histological Data. Kidney International, 45, 544-550. https://doi.org/10.1038/ki.1994.70
[5]
Mitjavila, F., Pac, V., Moga, I. and Poveda, R. (1997) Clinicopatho Logical Correlations and Prognostic Factors in Lupus Nephritis. Clinical and Experimental Rheumatology, 15, 625-631.
[6]
Esdail, J.M., Abrahamowicz, M., Joseph, L., McKenzie, T., Li, Y. and Danoff, D. (1996) Laboratory Tests as Predictors of Disease Exacerbations in Systemic Lupus Erythematosus. Arthritis & Rheumatology, 39, 370-378.
https://doi.org/10.1002/art.1780390304
[7]
Balow, J.E., Boumpas, D.T., Fessler, B.J. and Austin, H.A. (1996) Management of Lupus Nephritis. Kidney International, 53, S88-S92.
[8]
Mojcik, C.F. and Klippel, J.H. (1997) End-Stage Renal Disease and Systemic Lupus Erythematosus. The American Journal of Medicine, 102, 425-426.
https://doi.org/10.1016/S0002-9343(97)80032-0
[9]
Ramos, E.L. (1991) Recurrent Diseases in the Renal Allograft. Journal of the American Society of Nephrology, 2, 109-121. https://doi.org/10.1681/ASN.V22109
